These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11365265)

  • 1. Thalidomide's long and winding road.
    Hanna L
    BETA; 1998 Apr; ():33-5, 42. PubMed ID: 11365265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide--the story goes on...
    Learned J
    Notes Undergr; 1998; (No 37):1, 7, 9. PubMed ID: 11365815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide study.
    Proj Inf Perspect; 1997 Jul; (22):14-5. PubMed ID: 11364572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide approved.
    Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide's comeback.
    Vazquez E
    Posit Aware; 1998; 9(4):53-4. PubMed ID: 11365634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rehabilitation of thalidomide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thalidomide comeback.
    HIV Hotline; 1998 May; 8(2):7, 9, 15. PubMed ID: 11365364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growing interest in thalidomide.
    Lowell B
    GMHC Treat Issues; 1995 May; 9(5):4-6. PubMed ID: 11362414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and HIV: several possible uses.
    Smith D
    AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():5. PubMed ID: 11365993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
    Shetty K
    Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide reconsidered.
    Nat Biotechnol; 1997 Oct; 15(10):929. PubMed ID: 9335035
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide: is it any wonder?
    Hampshire M
    Nurs Times; 1998 Aug 26-Sep 1; 94(34):14-5. PubMed ID: 9791503
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide trial to begin.
    Posit Aware; 1997; 8(2):15. PubMed ID: 11364451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide. A surprising recovery.
    Stirling D; Sherman M; Strauss S
    J Am Pharm Assoc (Wash); 1997; NS37(3):306-13. PubMed ID: 9170807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide Celgene Corp.
    Bruyn GA
    IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of thalidomide.
    Trapnell CB
    AIDS Clin Care; 1998 Jan; 10(1):3, 8. PubMed ID: 11365075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The problem with thalidomide's new incarnation.
    Nat Biotechnol; 1998 Aug; 16(8):695. PubMed ID: 9702750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thalidomide once more in the spotlight].
    de Jong-van den Berg LT; Rutgers J; Cornel MC
    Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2509-12. PubMed ID: 10028338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide's elusive access.
    Gilden D
    GMHC Treat Issues; 1995 Nov; 9(11):11-2. PubMed ID: 11362987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.